1. Home
  2. WEX vs BLCO Comparison

WEX vs BLCO Comparison

Compare WEX & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WEX Inc. common stock

WEX

WEX Inc. common stock

HOLD

Current Price

$177.81

Market Cap

5.5B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.74

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEX
BLCO
Founded
1983
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.9B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
WEX
BLCO
Price
$177.81
$16.74
Analyst Decision
Hold
Buy
Analyst Count
10
12
Target Price
$164.60
$18.45
AVG Volume (30 Days)
375.2K
355.0K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
12.93
N/A
EPS
8.47
N/A
Revenue
$2,660,800,000.00
$5,101,000,000.00
Revenue This Year
$4.25
$8.65
Revenue Next Year
$4.94
$5.59
P/E Ratio
$20.45
N/A
Revenue Growth
1.24
6.47
52 Week Low
$120.03
$10.45
52 Week High
$180.71
$18.92

Technical Indicators

Market Signals
Indicator
WEX
BLCO
Relative Strength Index (RSI) 70.26 52.39
Support Level $146.07 $16.35
Resistance Level $178.22 $16.81
Average True Range (ATR) 6.70 0.44
MACD 2.37 0.11
Stochastic Oscillator 95.06 76.02

Price Performance

Historical Comparison
WEX
BLCO

About WEX WEX Inc. common stock

WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: